AN ASSOCIATION OF THE CLINICAL MANIFESTATIONS OF NSAID GASTROPATHY WITH UPPER GASTROINTESTINAL MOTOR DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2011-569
Abstract
Objective: to evaluate upper gastrointestinal (GI) motor disorders in diclofenac sodium-treated patients with rheumatoid arthritis (RA), by using 24-hour pH-metry, and their association with the clinical manifestations of gastropathy induced by nonsteroidal anti-inflammatory
drugs (NSAIDs) (NSAID gastropathy).
Subjects and methods. A study group included 39 patients diagnosed as having RA, 14 subjects formed a control group. All the included subjects underwent a clinical examination, endoscopic studies of the esophagus, stomach, and duodenum, and 24-hour gastric and esophageal pH monitoring (Gastroscan-24, Istok-Sistema Research-and-Production Association, Fryazino, Moscow Region). Results and discussion. Comparing the results of 24-hour intraesophageal and intragastric pH studies in RA patients and healthy individuals revealed differences in nocturnal acidity values. The RA group showed lower nocturnal pH values than the controls (p < 0.05). The obtained pH values may indirectly suggest that the RA patients have duodenogastroesophageal reflux. Analysis of 24-hour pH metric readings indicated the concurrence of gastroesophageal and duodenogastric refluxes in 37%. It is in this group that displayed a clinical decussation of pain and dyspeptic syndromes (p < 0.05).
Conclusion. The upper GI motor disorders found in the RA patients taking NSAIDs may play an important role in the development of clinical manifestations of NSAID gastropathy and, probably, a certain group of patients must undergo medical correction of the symptoms related to dysmotility.
drugs (NSAIDs) (NSAID gastropathy).
Subjects and methods. A study group included 39 patients diagnosed as having RA, 14 subjects formed a control group. All the included subjects underwent a clinical examination, endoscopic studies of the esophagus, stomach, and duodenum, and 24-hour gastric and esophageal pH monitoring (Gastroscan-24, Istok-Sistema Research-and-Production Association, Fryazino, Moscow Region). Results and discussion. Comparing the results of 24-hour intraesophageal and intragastric pH studies in RA patients and healthy individuals revealed differences in nocturnal acidity values. The RA group showed lower nocturnal pH values than the controls (p < 0.05). The obtained pH values may indirectly suggest that the RA patients have duodenogastroesophageal reflux. Analysis of 24-hour pH metric readings indicated the concurrence of gastroesophageal and duodenogastric refluxes in 37%. It is in this group that displayed a clinical decussation of pain and dyspeptic syndromes (p < 0.05).
Conclusion. The upper GI motor disorders found in the RA patients taking NSAIDs may play an important role in the development of clinical manifestations of NSAID gastropathy and, probably, a certain group of patients must undergo medical correction of the symptoms related to dysmotility.
References
1. <div><p>Каратеев А.Е. НПВП-ассоциированная патология верхних отделов ЖКТ: современное состояние проблемы -http://medi.ru/doc <http://medi.ru/doc></p><p>Циммерман Я.С., Циммерман И.Я. Гастродуоденальные эрозивно-язвенные повреждения, индуцированные приемом нестероидных противовоспалительных препаратов. Клин. мед. 2008; 2: 8-14.</p><p>Alonso-Ruiz A., Pijoan J., Ansuategui E. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and meta-analysis of efficacy and safety. BMC Musculoskelet Disord 2008; 9: 52.</p><p>Wallace J.L. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself. Physiol Rev 2008; 88: 1547-65.</p><p>Scarpignato C., Hunt R.H. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am 2010; 39(3): 433-64.</p><p>Lanas A. A review of the gastrointestinal safety data - a gastroenterologist's perspective. Rheumatology (Oxford) 2010; 49: 3-10.</p><p>Насонов Е.Л., Каратеев А.Е. Поражения желудка, связанные с приемом нестероидных противовоспалительных препаратов. Клин. мед. 2000; 3: 4-10 (ч. 1); 4: 4-9 (ч. 2).</p><p>Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. Под ред. А.Е. Каратеева. М.: ИМА-ПРЕСС, 2009; 167 с.</p><p>Дроздов В.Н. Гастропатии, вызванные НПВП: патогенез, профилактика и лече- ние. Consilium medicum 2005; 1(прил.): 3-6.</p><p>Bassotti G., Bucaneve G., Furno P. Double-blind, placebo-controlled study on effect of diclofenac sodium and indometacin on post-prandial gastric motility in men. Dig Dis Sci 1998; 43: 1172-6.</p><p>Каратеев А.Е., Насонов Е.Л. Нестероидные противовоспалительные препараты и верхние отделы желудочно-кишечного тракта: патология, не связанная с развитием язв и эрозий. Рус. мед. журн. 2002; 10(28): 28-30.</p><p>Lanza F.L. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other non-steroidal antiinflammatory agents. Am J Med 1984; 77: 19-24.</p><p>Ильченко А.А., Селезнева Э.Я. Компьютерная рН-метрия желудка и пищевода. Клиническое значение метода: Метод. рекомендации №15. М.: Департамент здравоохранения Правительства Москвы, 2001; 40 с.</p><p>Рапопорт С.И., Лакшин А.А., Ракитин Б.В. рН-метрия пищевода и желудка при заболеваниях верхних отделов пище- варительного тракта. Под ред. акад. РАМН Ф.И. Комарова. М., 2005; 208 с.</p></div><br />
Review
For citations:
Abdulganiyeva D., Belyanskaya N.E., Nasonov E.L. AN ASSOCIATION OF THE CLINICAL MANIFESTATIONS OF NSAID GASTROPATHY WITH UPPER GASTROINTESTINAL MOTOR DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2011;49(3):25-28. (In Russ.) https://doi.org/10.14412/1995-4484-2011-569
Views:
822
Email this article 